Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

Riyad Capital forecasts Q3 profit for Dr. Sulaiman Al Habib Medical Services stock

Published on 10/19/2026 at 09:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Riyad Capital projects SAR 672 million third-quarter 2026 profit. Dr. Sulaiman Al Habib Medical Services stock has a SAR 77.4 billion market value.

Forecasts frame the next quarter

Riyad Capital projected SAR 672 million in net profit for the third quarter of 2026 on October 12, 2026.
GIB Capital forecast SAR 670 million and 11.20 percent year-over-year growth on October 11, 2026.
Revenue reached SAR 13.7 billion in fiscal year 2025, compared with SAR 11.2 billion in fiscal year 2024.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

Dr. Sulaiman Al Habib Medical Services stock was last at SAR 221.00 on October 19, 2026 at 10:01 a.m. AST, while Global Banking and Finance identifies the Saudi-listed company under ticker 4013 and ISIN SA1510P1UMH1. The latest market catalyst is a set of third-quarter earnings forecasts published by Argaam between October 7 and October 12, 2026.

Three forecasts set the earnings frame

On October 7, 2026, Value Capital projected SAR 688.0 million in third-quarter net profit for Sulaiman Al Habib, up 14.00 percent year over year, according to Argaam. On October 11, GIB Capital forecast SAR 670 million, representing an 11.20 percent increase, in a separate Argaam report. Riyad Capital followed on October 12 with a SAR 672 million estimate and 12.00 percent year-over-year growth, also reported by Argaam.

What does the forecast mean for earnings?

The three estimates cluster between SAR 670 million and SAR 688.0 million, giving investors a quantified range rather than a single consensus figure. The growth assumptions also run from 11.20 percent to 14.00 percent, keeping year-over-year expansion at the center of the upcoming results discussion.

Revenue growth supports the comparison

Reuters lists fiscal-year 2025 revenue at SAR 13.7 billion, compared with SAR 11.2 billion in fiscal year 2024. That is a 22.38 percent increase. Fiscal-year 2025 net income was SAR 2.4 billion, versus SAR 2.3 billion in fiscal year 2024, a 3.72 percent rise. Operating cash flow reached SAR 3.4 billion in fiscal year 2025, compared with SAR 3.0 billion in fiscal year 2024.

Stock valuation and next steps

The October 19, 2026 Tadawul indication of SAR 221.00 places the company at a market capitalization of SAR 77.4 billion. The same session showed a 52-week range of SAR 210.10 to SAR 280.40, leaving the share price SAR 11.00 above the yearly low and SAR 59.40 below the yearly high. The next material company date is the third-quarter reporting period covered by the forecasts; a specific reporting day was not included in the cited reports.